EP3755688
INDÓL OG BENSÍMÍDAZÓL AFLEIÐUR SEM TVÖFALDIR 5-HT2A OG 5-HT6 VIÐTAKABLOKKAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.2.2019EP published:
14.6.2023EP application number:
19706271.4
EP translation filed:
24.7.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
19.2.2039Expiry date:
19.2.2026Next due date:
28.2.2026
Title in English:
INDOLE AND BENZIMIDAZOLE DERIVATIVES AS DUAL 5-HT2A AND 5-HT6 RECEPTOR ANTAGONISTSLanguage of the patent:
English
Timeline
Today
20.2.2019EP application
14.6.2023EP Publication
24.7.2023Translation submitted
15.8.2023Registration published
19.2.2026Expires
Owner
Name:
Adamed Pharma S.A.Address:
Pienkow ul. Mariana Adamkiewicza 6A, 05-152 Czosnow, PL
Inventor
Name:
KOLACZKOWSKI, MarcinAddress:
32-020 Wieliczka, PL
Name:
BUCKI, AdamAddress:
32-020 Przebieczany, PL
Name:
SNIECIKOWSKA, JoannaAddress:
32-020 Wieliczka, PL
Name:
MARCINKOWSKA, MonikaAddress:
31-267 Krakow, PL
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
18461519Date:
21.2.2018Country:
EP
Classification
Categories:
C07D 209/10, C07D 235/10, A61P 25/00, A61P 25/16, A61P 25/18, A61P 25/24, A61P 25/28, A61K 31/496
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 29.2.2024
Expires: 19.2.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 13.2.2025
Expires: 19.2.2026
Payer: Árnason Faktor ehf.